A
Alexia Piperidou
Researcher at Aristotle University of Thessaloniki
Publications - 9
Citations - 358
Alexia Piperidou is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Albuminuria & Population. The author has an hindex of 6, co-authored 8 publications receiving 163 citations.
Papers
More filters
Journal ArticleDOI
The Growing Epidemic of Diabetes Mellitus.
Dragan Lovic,Alexia Piperidou,Ioanna Zografou,Haralambos Grassos,Andreas Pittaras,Athanasios J. Manolis +5 more
TL;DR: In order to monitor the public-health strategies and design effective future interventions the authors need reliable global estimates regarding the prevalence of DM, and the urgent need for effective interventions is realized.
Journal ArticleDOI
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients
Pantelis Sarafidis,Charalampos Loutradis,Antonios Karpetas,Georgios Tzanis,Alexia Piperidou,Georgios Koutroumpas,Vasilios Raptis,Christos Syrgkanis,Vasilios Liakopoulos,Georgios Efstratiadis,G. London,Carmine Zoccali +11 more
TL;DR: It is found that arterial stiffness is the prominent cardiovascular risk factor in hemodialysis and Ambulatory PWV, AIx(75), and central pulse pressure are associated with increased risk of cardiovascular events and mortality, whereas office and ambulatory SBP are not.
Journal ArticleDOI
Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Maria-Eleni Alexandrou,Aikaterini Papagianni,Apostolos Tsapas,Charalampos Loutradis,Afroditi K. Boutou,Alexia Piperidou,Dorothea Papadopoulou,Luis M. Ruilope,George L. Bakris,Pantelis Sarafidis +9 more
TL;DR: Use of MRAs alone or on top of RAS blockade confers important antiproteinuric effects in patients with CKD, with a slight increase in mean potassium levels.
Journal ArticleDOI
The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Alexia Piperidou,Pantelis Sarafidis,Afroditi K. Boutou,Costas Thomopoulos,Charalampos Loutradis,Maria Eleni Alexandrou,Apostolos Tsapas,Asterios Karagiannis +7 more
TL;DR: SGLT-2 inhibitors were associated with statistically significant reduction in albuminuria compared to placebo or active control, and reduction in urine albumin-to-creatinine ratio was more prominent in randomized controlled trials in patients with moderately or severely increasedalbuminuria.
Journal ArticleDOI
SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives
TL;DR: The present review summarizes the current evidence from human trials on the effects of SGLT-2 inhibitors on nephroprotection and discusses their position in everyday clinical practice.